CLINICAL_TRIALS
trial_result
· 2017-01-04
Clinical Trial Update: Melatonin and Glucose Tolerance Among Individuals With a Variant of the MTNR1B Gene [Phase 3]
Summary
A Phase 3 clinical trial evaluating the effect of melatonin on glucose tolerance in individuals with an MTNR1B gene variant has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Helsinki | Conditions: Diabetes, Glucose Tolerance | Phase 3 | Status: COMPLETED